Mativ (MATV) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
6 Aug, 2026Executive summary
Achieved strongest quarterly performance since company inception, with sales up 1.2% year-over-year to $531.8 million and GAAP net income of $3.6 million, reversing a prior-year loss.
Adjusted EBITDA rose 12% to $75.0 million, with margin up 130 basis points to 14.1%.
Free cash flow increased 24% year-over-year to $60.4 million, reflecting robust operational performance.
Strategic focus on innovation, customer partnerships, and operational excellence driving results.
Net income for the quarter was $3.6 million, reversing a net loss of $9.5 million in Q2 2025; diluted EPS was $0.06.
Financial highlights
Net sales reached $531.8 million, up from $525.4 million year-over-year; gross profit was $113.3 million, up 9.3%.
Adjusted EPS was $0.50, up from $0.33; GAAP EPS was $0.06, up from $(0.18).
Operating profit for Q2 was $35.3 million, up from $20.1 million in Q2 2025.
Cash from operating activities was $67.9 million, up 18% year-over-year.
Net debt reduced to $908.2 million, down from $934.0 million at year-end; total liquidity was $345.5 million.
Outlook and guidance
Expect modest volume growth in Q3, led by advanced films, despite tornado-related headwinds.
Full-year inflation impact projected at $40–$50 million, with cost increases weighted to the second half.
Net leverage targeted in the mid-to-high 3x range by year-end, aiming for 2.5x–3.5x by mid-2027.
Management expects continued benefits from pricing actions and cost optimization, with sufficient liquidity to support operations and growth.
No material impact from recent U.S. tariff changes or tax legislation is anticipated for 2026.
Latest events from Mativ
- SaaS/SAS growth and cost actions offset FAM headwinds, positioning for profit gains in 2025.MATV
Q4 202430 Jun 2026 - All proposals passed, including director elections and equity plan amendment, with no questions raised.MATV
AGM 20269 May 2026 - Adjusted EBITDA rose 28% to $47.5M, with margin gains and leverage reduced to 4.1x.MATV
Q1 20267 May 2026 - Record free cash flow and EBITDA gains in 2025, despite a major goodwill impairment.MATV
Q4 202510 Apr 2026 - Operational transformation and targeted investments drive growth and margin expansion.MATV
Investor presentation25 Mar 2026 - Annual meeting to vote on directors, auditor, compensation, and equity plan amendment.MATV
Proxy Filing17 Mar 2026 - Proxy covers director elections, auditor ratification, compensation, and equity plan amendment.MATV
Proxy Filing17 Mar 2026 - Adjusted EBITDA rose 13% year-over-year, with margin and cash flow improvements in Q2 2024.MATV
Q2 20242 Feb 2026 - Adjusted EBITDA up 10% on flat sales; SAS growth offsets FAM headwinds amid restructuring.MATV
Q3 202416 Jan 2026